Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Skolnick Phil
Relationship:   Chief Scientific Officer
City:   Hackensack
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   0    

Indirect Shares

   0      
Direct Value   $0    

Indirect Value

   $0      
Total Shares   0      
Total Value   $0      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    6    

     Stock price went up :
    0   
    4    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   2.0   
     Percentage Gain/Loss :
     0.0%
 -40.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Opiant Pharmaceuticals Inc OPNT Chief Scientific Officer 2023-03-02 0 2018-10-02 0    Premium*  
* Premium Members only  

Records found :    64         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2020-01-07 4 A $0.00 $0 D/D 4,150 10,035 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2021-01-26 4 A $0.00 $0 D/D 8,198 12,348 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2022-01-04 4 A $0.00 $0 D/D 12,000 24,348 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2022-06-27 4 A $0.00 $0 D/D 2,000 24,445 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2023-03-02 4 A $0.00 $0 D/D 2,000 2,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2018-10-02 4 OE $9.00 $43,002 D/D 4,778 4,778 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2018-12-03 4 OE $9.00 $38,889 D/D 4,321 4,321 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-01-02 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-02-01 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-03-01 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-04-01 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-05-01 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-06-03 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-07-01 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-08-01 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-09-03 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-10-01 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-11-01 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-12-02 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2020-01-02 4 OE $9.00 $90,000 D/D 10,000 10,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-05-02 4 AS $11.24 $16,197 D/D (1,441) 0 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-08-02 4 AS $11.30 $17,605 D/D (1,558) 0 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-05-01 4 AS $11.41 $97,658 D/D (8,559) 1,441 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-06-04 4 AS $11.63 $18,445 D/D (1,586) 0 0 -
OPNT Opiant Pharmaceuticals In... Chief Scientific Officer   •       –      –    2019-08-01 4 AS $11.66 $98,434 D/D (8,442) 1,558 0 -
  64  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us